메뉴 건너뛰기




Volumn 2, Issue 9, 2005, Pages 0828-0832

Erratum: A breakthrough in R&D for neglected diseases: New ways to get the drugs we need (PLoS Medicine (2005) 2:9 DOI: 10.1371/journal.pmed.0020302);A breakthrough in R&D for neglected diseases: New ways to get the drugs we need

Author keywords

[No Author keywords available]

Indexed keywords

DRUG INDUSTRY; DRUG RESEARCH; FINANCIAL MANAGEMENT; GOVERNMENT; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HUMAN; INTERNET; INVESTMENT; REVIEW; TROPICAL DISEASE; ARTICLE; DRUG DESIGN; DRUG MANUFACTURE; ECONOMICS; INTERNATIONAL COOPERATION; MEDICAL RESEARCH; ORGANIZATION AND MANAGEMENT; RARE DISEASE;

EID: 25644443165     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.0020376     Document Type: Erratum
Times cited : (148)

References (7)
  • 1
    • 0039830077 scopus 로고    scopus 로고
    • Access to essential drugs in poor countries: A lost battle?
    • Pecoul B, Chirac P, Trouiller P, Pinel J (1999) Access to essential drugs in poor countries: A lost battle? JAMA 281: 361-367.
    • (1999) JAMA , vol.281 , pp. 361-367
    • Pecoul, B.1    Chirac, P.2    Trouiller, P.3    Pinel, J.4
  • 2
    • 25644443567 scopus 로고    scopus 로고
    • March 2005
    • Commission for Africa (2005) Final report: "Our common interest". March 2005. Available: http://www.commissionforafrica.org/ english/report/ thereport/english/11-03-05_cr_report.pdf. Accessed 29 July 2005.
    • (2005) Final Report: "Our Common Interest"
  • 3
    • 0037374498 scopus 로고    scopus 로고
    • The price of innovation: New estimates of drug development costs
    • DiMasi J, Hansen R, Grabowski H (2003) The price of innovation: New estimates of drug development costs. J Health Econ 22: 325-330.
    • (2003) J Health Econ , vol.22 , pp. 325-330
    • DiMasi, J.1    Hansen, R.2    Grabowski, H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.